Nomura Holdings’s Novavax NVAX Stock Holding History

Nomura Holdings’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$814K	Buy	+100,000	New	+$906K	﹤0.01%	1224
2025 Q4	–	Sell	-148,300	Closed	-$1.29M	–	2082
2025 Q3	$1.29M	Buy	148,300 +48,300	+48%	+$376K	﹤0.01%	1313
2025 Q2	$630K	Buy	100,000 +48,000	+92%	+$318K	﹤0.01%	1094
2025 Q1	$333K	Buy	+52,000	New	+$430K	﹤0.01%	1581
2024 Q3	–	Sell	-42,000	Closed	-$532K	–	1863
2024 Q2	$532K	Buy	+42,000	New	+$423K	﹤0.01%	1314
2015 Q1	–	Sell	-3,750	Closed	-$442K	–	2123
2014 Q4	$442K	Hold	3,750	–	–	﹤0.01%	1678
2014 Q3	$313K	Buy	+3,750	New	+$339K	﹤0.01%	2141

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nomura Holdings's NVAX Position: Q1 2026 in Review

Nomura Holdings opened a new position in Novavax (NVAX) in Q1 2026: 90,896 shares worth $740K. The stake represents ﹤0.01% of the portfolio and ranks #1252 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in NVAX as recently as Q1 2025.

Nomura Holdings first reported a position in NVAX in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.95M in Q4 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Nomura Holdings held 90,896 shares of Novavax worth $740K as of Q1 2026.
Novavax was a new Nomura Holdings position in Q1 2026.
Novavax made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1252 holding.
Nomura Holdings first reported a position in Novavax in Q2 2013 and has held it in 15 quarters since.
Nomura Holdings's Novavax position peaked at $4.95M in Q4 2021.
258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.